Fasenra for Treating Severe Eosinophilic Asthma

Fasenra is a monoclonal antibody that targets and reduces eosinophils and is used in the treatment of severe eosinophilic asthma. It is administered through an injection.
Category
Drug
Where to get
Available by prescription, administered in a clinical setting.
Benralizumab
Monoclonal antibody targeting the IL-5 receptor
Prepared by Lee Cheng, reviewed by Dr. Helena Rodriguez

Fasenra FAQ


Image credit: dibesity.com

How many doses of Fasenra are in a syringe?

Each syringe or pen contains one dose of Fasenra. Both forms of the drug have one strength: 30 mg/mL. During the first 3 months of treatment, you’ll have one injection (30 mg/mL) once every 4 weeks. After that, you’ll have one injection once every 8 weeks. The dosage of Fasenra for children ages 12 years and older is the same as for adults.

What is the difference between Fasenra and Nucala?

Fasenra and Nucala are kinds of biologic medications, which means they’re made from living cells rather than chemicals. And they’re both given as an injection under the skin. To learn more about how Fasenra and Nucala are alike and different, check out this side-by-side comparison.

What are the most common side effects of Fasenra?

The most common side effects of FASENRA include: headache and sore throat. These are not all the possible side effects of FASENRA. FASENRA is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in people 12 years and older whose asthma is not controlled with their current asthma medicines.

What is Fasenra used for?

FASENRA is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in people 12 years and older whose asthma is not controlled with their current asthma medicines. FASENRA is not used to treat other problems caused by eosinophils and is not used to treat sudden breathing problems.

How does Fasenra work in eosinophilic asthma?

In a 56-week clinical trial, FASENRA reduced the occurrence of severe asthma attacks by 28% compared with placebo + existing medicines. See how FASENRA impacted the lives of real people living with eosinophilic asthma. The mechanism of action of FASENRA in asthma is not fully understood. Fewer doses per year than with other treatment options.

Can Fasenra help with asthma?

Fasenra may reduce the number of asthma attacks you are experiencing, help you breathe better and decrease your asthma symptoms. If you are taking medicines called ‘oral corticosteroids’, using Fasenra may also allow you to reduce the daily dose or stop the oral corticosteroids you need to control your asthma. 2.

Fasenra References

If you want to know more about Fasenra, consider exploring links below:

Explore Related Topics

The Evolution of AI in Asthma Management: From Concept to Clinic

Tracing the journey of AI technology from initial concept to practical application in clinical asthma management.

The Role of Monoclonal Antibodies in Pediatric Asthma Treatment

Discussing the use of monoclonal antibodies in treating severe asthma among children, share your concerns, experiences, or questions.

Monoclonal Antibodies and Asthma: Debunking Myths

There are many myths surrounding the use of monoclonal antibodies in asthma treatment. Let's debunk these myths and spread factual information.

The Role of Allergy Testing Before Starting Immunotherapy for Asthma

Delve into the importance of allergy testing before commencing immunotherapy for asthma, including what tests are involved and why they're necessary.

How to Advocate for Access to Monoclonal Antibody Treatments

Gaining access to monoclonal antibody treatments can be a challenge for many. Share tips and experiences on advocating for yourself or loved ones.

How Immunotherapy for Asthma Fits into Long-term Management Plans

Discuss how immunotherapy integrates with other asthma management plans for long-term control and quality of life improvements. Share tips and strategies.

Breaking Down Steroid Resistance in Asthma: Myth or Reality?

Explore the concept of steroid resistance in asthma. Is it a significant concern or a rare occurrence? Share your insights or questions.

Understanding the Different Types of Monoclonal Antibodies for Asthma

With various monoclonal antibodies available for asthma, navigating the options can be complex. Join the discussion to understand the differences.

Navigating Insurance and Access to Biologic Therapies for Asthma

Discuss the challenges and solutions related to insurance coverage and access to biologic treatments for asthma.

Understanding the Risks vs. Benefits of Immunotherapy for Asthma

Weigh the risks against the benefits of undergoing immunotherapy for asthma. Share resources, expert opinions, and personal viewpoints to help others make informed decisions.

Immunotherapy Success Stories: Has It Improved Your Asthma?

Share your personal success stories about how immunotherapy has improved your asthma. Inspire others with real-life experiences and outcomes.

The Role of Immunotherapy in Childhood Asthma Control

Exploring the benefits and considerations of using immunotherapy for managing asthma in allergic children. Could allergy shots be the shot at relief your child needs?

The Psychological Impact of Severe Asthma: How Do You Cope?

Living with severe asthma can be challenging. How do you deal with the fear and anxiety of potential exacerbations? Share your coping mechanisms.

Assistance Programs for Asthma Medication: Yay or Nay?

Share experiences with pharmaceutical assistance programs for asthma medication. Are they helpful? Let's discuss the pros and cons.

The Cost of Immunotherapy: Is It Worth It for Asthma Patients?

Delve into the cost-effectiveness of immunotherapy for asthma treatment. Share insights on whether the benefits justify the expenses.

Who Qualifies for Monoclonal Antibody Treatments for Asthma?

Navigating the criteria for monoclonal antibody treatments can be confusing. Let's break down who benefits most from this advanced therapy.

Biologics: The Future of Personalized Asthma Therapy?

Investigating the impact of biologic medications on personalized asthma therapy and if they are shaping the future of asthma care.

Can Monoclonal Antibodies Improve Quality of Life for Severe Asthma Patients?

If you or someone you know has experienced the impact of monoclonal antibodies on severe asthma, share your stories here. Let's discuss the quality of life improvements.

Who is Eligible for Asthma Immunotherapy?

Explore the criteria that determine whether a patient with asthma is a good candidate for immunotherapy. Discuss the factors that doctors consider before recommending this treatment.

How Do Monoclonal Antibodies Target Asthma Differently Than Traditional Medications?

Monoclonal antibodies promise a targeted approach to asthma management, but how do they compare with traditional treatments? Join the conversation.

Biologic Therapies for Asthma: Hope or Hype?

Delve into the world of biologic therapies for severe asthma, understanding their mechanism, benefits, and potential limitations.

What Are the Long-Term Effects of Monoclonal Antibody Treatments?

Understanding the long-term implications is crucial for those considering monoclonal antibody treatments for severe asthma. Share your insights or concerns here.

Is Immunotherapy the Breakthrough We've Been Waiting for in Asthma Treatment?

This thread invites members to discuss the revolutionary potential of immunotherapy in treating asthma. Does it live up to the expectation of being a significant breakthrough?

Is Immunotherapy a Game Changer for Asthma Sufferers?

This thread aims to explore the impact of immunotherapy on asthma management and its potential to change the lives of those affected. Discuss your experiences and thoughts about this emerging treatment.